Avalon Ventures

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2016. It specializes in drug discovery, particularly focusing on solute carrier (SLC) transporters, which are vital for understanding various disease pathways. The company’s efforts are directed towards immunometabolism, lysosomal function, and mucosal defense, with applications in immuno-oncology, inflammatory disorders, and neurological diseases. Utilizing its proprietary RAPID platform, Jnana accelerates the identification of therapeutic targets and the development of small molecule therapies. By leveraging advanced chemoproteomics techniques, the company aims to enhance the efficiency of drug discovery and address significant unmet medical needs in patient care.

Nanigans is a Boston-based company that specializes in advertising automation software, designed to support in-house performance marketing teams. As a Software-as-a-Service provider, Nanigans offers a platform that features programmatic media buying, predictive revenue optimization, and real-time business intelligence. This comprehensive approach allows clients to enhance their advertising strategies and optimize revenue generation across various digital channels. In addition to its headquarters in Boston, Nanigans has established offices in New York, San Francisco, Seattle, London, Sydney, and Singapore, reflecting its global reach and commitment to serving a diverse client base.

Nanigans is a Boston-based company that specializes in advertising automation software, designed to support in-house performance marketing teams. As a Software-as-a-Service provider, Nanigans offers a platform that features programmatic media buying, predictive revenue optimization, and real-time business intelligence. This comprehensive approach allows clients to enhance their advertising strategies and optimize revenue generation across various digital channels. In addition to its headquarters in Boston, Nanigans has established offices in New York, San Francisco, Seattle, London, Sydney, and Singapore, reflecting its global reach and commitment to serving a diverse client base.

Founded in 2006, Techstars is a global platform that supports and invests in early-stage technology companies. Through its mentorship-driven accelerator programs, seed investments, and venture capital fund, Techstars fosters innovation across various sectors worldwide.

Nanigans is a Boston-based company that specializes in advertising automation software, designed to support in-house performance marketing teams. As a Software-as-a-Service provider, Nanigans offers a platform that features programmatic media buying, predictive revenue optimization, and real-time business intelligence. This comprehensive approach allows clients to enhance their advertising strategies and optimize revenue generation across various digital channels. In addition to its headquarters in Boston, Nanigans has established offices in New York, San Francisco, Seattle, London, Sydney, and Singapore, reflecting its global reach and commitment to serving a diverse client base.